Sensorion Reports Data in the Audiogene Phase 1/2 Gene Therapy Clinical Trial
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, announced today latest data updates confirming...